Cargando…

10. Kinetics of Post-Vaccination Seroprotection to S. Pneumonia for the Immune-Compromised and Vaccine-Naïve Populations

BACKGROUND: S. pneumonia infection presents a significant challenge, accounting for 20–38% of hospital-acquired pneumonia, and the leading cause of community-acquired pneumonia despite availability of effective vaccines. Incidence is highest in children under 2 years, the immunocompromised, and elde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruenglas, Jeffrey, Mond, James, Scobie, Micaela, Tolman, Cynthia, Martinez, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776110/ http://dx.doi.org/10.1093/ofid/ofaa439.055

Ejemplares similares

1057. CpG-adjuvanted Hepatitis B vaccination improves seroprotection rates in Veterans with HIV
por: Deming, Meagan, et al.
Publicado: (2020)

HBV Seroprotection and Anamnestic Response to Booster Vaccination in Pediatric Cancer Survivors
por: Suwanpakdee, Detchvijitr, et al.
Publicado: (2021)

1051. Rapid onset of seroprotection rates in young adults immunized with a tri-antigenic hepatitis B virus (HBV) vaccine compared to a mono-antigenic HBV vaccine
por: Vesikari, Timo, et al.
Publicado: (2020)

High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post–Autologous Stem Cell Transplant Period
por: Hall, Victoria G, et al.
Publicado: (2023)

Long-Term Persistence of Seroprotection by Hepatitis B Vaccination in Healthcare Workers of Southern Italy
por: Grosso, Giuseppe, et al.
Publicado: (2012)

Seroprotection against tetanus in southern Vietnam
por: Thwaites, C. Louise, et al.
Publicado: (2023)

Rates of Seroprotection against Vaccine-Preventable Infectious Diseases in HIV-Exposed and -Unexposed Malawian Infants
por: Baroncelli, Silvia, et al.
Publicado: (2023)

Observational Study Evaluating the Seroprotection of HepB-alum Vaccine and HepB-CpG Vaccine in People With HIV
por: Reilly-Evans, Brenna, et al.
Publicado: (2023)

21. Current and Nadir CD4+ Counts Are Associated with Heplisav-B Seroprotection Rates in People with HIV
por: Schnittman, Samuel, et al.
Publicado: (2020)

Hepatitis B Seroprotection and the Response to a Challenging Dose among Vaccinated Children in Red Sea Governorate
por: Sami, Samia M., et al.
Publicado: (2016)

Seroprotection against Vaccine-Preventable Diseases amongst Health Care Workers in a Community Hospital, Qatar
por: Guanche Garcell, H, et al.
Publicado: (2016)

Impact of hepatitis B immunization among the Nicobarese tribe - antibody titres & seroprotection five years after vaccination
por: Sugunan, A. P., et al.
Publicado: (2014)

Seroprotection after hepatitis B vaccination in children aged 1 to 15 years in central province of Iran, Semnan
por: REZAEI, M., et al.
Publicado: (2014)

Seroprotection of Hepatitis B Vaccine in Dental Students Two Decades after Infant Immunization and the Possible Need for Revaccination
por: Lingawi, Hanadi S., et al.
Publicado: (2022)

Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?
por: Tohme, Rania A., et al.
Publicado: (2023)

Age-specific seroprotection after Hepatitis B virus vaccination among Korean American pediatric population in Queens, New York
por: Min, Esther, et al.
Publicado: (2022)

Potential biases arising from epidemic dynamics in observational seroprotection studies
por: Kahn, Rebecca, et al.
Publicado: (2020)

Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies
por: Kahn, Rebecca, et al.
Publicado: (2020)

Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013–2014
por: Cheng, Alvan, et al.
Publicado: (2022)

2771. Seroprotection against Measles, Rubella, Tetanus, and Diphtheria Among Children in Haiti—2017
por: Minta, Anna A, et al.
Publicado: (2019)

1056 Factors Associated with Pre-season Seroprotection to B Lineage Influenza Viruses in Children
por: King, Jennifer, et al.
Publicado: (2014)

Different Long-Term Duration of Seroprotection against Neisseria meningitidis in Adolescents and Middle-Aged Adults after a Single Meningococcal ACWY Conjugate Vaccination in The Netherlands
por: Ohm, Milou, et al.
Publicado: (2020)

IFN-γ secreting capacity of CD8+T cell is compromised with the increased copies of epitope encoding sequences in DNA vaccine design
por: Wang, J, et al.
Publicado: (2012)

In vitro SIV replication kinetics correlate with vaccine induced cellular immune responses and predict post-challenge outcome in immunized rhesus macaques
por: Ochieng, Washingtone, et al.
Publicado: (2006)

Vaccination of immune compromised children—an overview for physicians
por: Pittet, Laure F., et al.
Publicado: (2021)

Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level
por: Lô, Gora, et al.
Publicado: (2019)

Low seroprotection rate for meningococcus serogroup C in the adult HIV-1-infected population in Austria
por: Grabmeier-Pfistershammer, Katharina, et al.
Publicado: (2019)

Lack of seroprotection against diphtheria in the Austrian population, in light of reported diphtheria cases in Europe, 2022
por: Wagner, Angelika, et al.
Publicado: (2023)

Naive CD8+ T cells from ART respond to primary vaccination against autologous HIV-1 antigen
por: Smith, Kellie N, et al.
Publicado: (2012)

Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population
por: Kudagammana, Sanath Thushara, et al.
Publicado: (2020)

Phase 1 dose escalation of ONT-10, a therapeutic MUC1 vaccine, in patients with advanced cancer
por: Nemunaitis, John, et al.
Publicado: (2013)

Different biological activity of CD154-SIVgp41 fusion protein vaccine component in naïve or pre-immune individuals
por: Smith, LM, et al.
Publicado: (2012)

The post-vaccine microevolution of invasive Streptococcus pneumoniae
por: Cremers, Amelieke J. H., et al.
Publicado: (2015)

Seroprotection at Different Levels of the Healthcare System After Routine Vaccination With Diphtheria-Tetanus-Pertussis whole cell–Hepatitis B–Haemophilus influenzae Type B in Lao People’s Democratic Republic
por: Hefele, Lisa, et al.
Publicado: (2019)

04. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Meningococcal Vaccine-Naive Participants Across a Broad Age Range (2-55 Years) in Japan
por: Matsuoka, Osamu, et al.
Publicado: (2021)

The response to Typhi Vi vaccination is compromised in individuals with primary immunodeficiency
por: Kumarage, Jeevani, et al.
Publicado: (2017)

Ophthalmologic compromise following SARS-CoV-2 vaccinations
por: Finsterer, Josef
Publicado: (2022)

Impact of Prevnar vaccination on nasopharyngeal carriage of Streptococcus pneumoniae in healthy children in New Caledonia
por: Scotet, Julie, et al.
Publicado: (2011)

P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
por: Basavapathruni, A, et al.
Publicado: (2009)

Persistent immunity after therapeutic vaccination targeting HER2/neu correlated with post-vaccination magnitude of interferon gamma Elispot responses
por: Liao, John B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q88v5abbft9th6fbjasgitdagv